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20 Oral Presentationsthan 12 months (Odds Ratio (OR) 3.7, CI 1.1, 11.8, P 5 .03) and
emotional distress pretransplant (OR 2.7, CI 1.0, 7.1, P5 .05). Re-
sults indicate that neuropsychological function continued to im-
proved from 1 to 5 years, but deficits remained for a third or
more of survivors in memory and motor dexterity.Impairment Rates at 5 Years
5 Year Survivors 5 Year Controls
Test % Impaired* % Impaired*Motor speed and dexterity
(Pegboard)43 17Verbal memory (HVLT) 32 20
Verbal fluency (COWAT) 20 14
Information processing
(Digit Symbol/Trails B)12/15 6/8*T scores in normative samples would have 15% impaired.48
A SIMPLIFIED SCORING SYSTEM TO PREDICT DAY 100 NON-RELAPSE
MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Basu, S.K.1, Liesveld, J.L.1, Trawick, D.R.2, Fernandez, D.3,
Nichols, D.1, Fisher, S.G.3. 1University of Rochester, Rochester, NY;
2University of Rochester, Rochester, NY; 3University of Rochester, Roches-
ter, NY.
This study’s purpose was to develop a scoring system using pa-
tient characteristics before hematopoietic stem cell transplantation
(HSCT) to predict the risk of early non-relapse mortality.
Methods: Patients undergoing their first HSCT at the Univer-
sity of Rochester from 1995 to 2004 were eligible. Non-relapse
mortality at 100 days (Day100NRM) was the primary outcome.
Sex, race, age, smoking status, body mass index, diagnosis, year,
transplant type, cell source, conditioning regimen, dose of nucle-
ated cells, diffusion capacity of the lung for carbon monoxide
(DLCO), forced expiratory volume at one second, forced vital ca-
pacity, creatinine, BUN, bilirubin, serum aspartate aminotransfer-
ase (AST), left ventricular ejection fraction, and albumin were
evaluated as independent variables. The study population was ran-
domly divided into two samples: an exploratory sample to construct
a prediction model with risk factors for Day100NRM and a valida-
tion sample to test this model. Results: Data regarding patient
characteristics were available on 677 (95%) patients. 507 subjects
(75%) were randomly selected to form the exploratory sample. Us-
ing logistic regression, related and unrelated allogeneic (versus au-
tologous) transplant, stem cells from bone marrow (versus
peripheral blood), low DLCO, low albumin, and high AST were
identified as statistically significant predictors of Day100NRM in
the exploratory sample (c-statistic 5 0.856). This model was suc-
cessfully validated (c-statistic 5 0.819) on the remaining 170 sub-
jects (validation sample) and on three random sub-samples of the
exploratory sample. Next, receiver operating characteristic curves
and classification tables were used to identify optimal cut-off points
to dichotomizeDLCO (\65,$65%predicted, corrected for hemo-
globin), AST (.40, #40 IU/L)) and albumin (\3.5, $3.5 g/dl) to
construct a scoring system for clinical use. This prediction model
was used to categorize patients into three groups- low, moderate,
or high risk of Day100NRM (see Table). There was an incremental
increase in risk of Day100NRM (2%, 13%, 39%) across the risk
groups. Conclusions: Type of transplant, stem cell source,
DLCO, AST, and albumin were predictive of Day100NRM, and
were used to construct a simplified scoring system. This pre-trans-
plant risk scoring system may be used for prognostication, and per-
haps to institute risk based targeted therapies. External validation is
necessary to determine its generalizability to other populations.Scoring System
Variable Variable ScoreDLCO (% predicted):\65 1
$65 0
AST (IU/L): .40 1
#40 0
Albumin (g/dl):\3.5 1
$3.5 0
Stem Cell source: Bone Marrow 1
Peripheral blood 0
Transplant: Unrelated donor 2
Related Donor 1
Autologous 0
Risk Group Total Score
Low Risk 0, 1
Moderate Risk 2
High Risk $349
RURAL-URBAN DISPARITIES IN SURVIVAL OUTCOME AFTER HEMATO-
POIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIG-
NANCIES
Rao, K.1, Darrington, D.L.2, Schumacher, J.J.2, DeVetten, M.P.2,
Vose, J.M.2, Loberiza, F.R.2. 1Brownell Talbott High School, Omaha,
NE; 2University of Nebraska Medical Center, Omaha, NE.
Background: We evaluated whether a patient’s area of primary
residence is an independent risk factor for overall survival (OS) after
HLA-identical sibling or autologous hematopoietic stem cell trans-
plantation (HSCT). Patients andMethods:This is a retrospective
study that included patients who received autologous HSCT (n 5
1739) for lymphoma and multiple myeloma (MM) or HLA-identi-
cal sibling (n5 267)HSCT for leukemias between 1983 and 2004 at
the University of Nebraska Medical Center. Primary area of resi-
dence using the patient’s zip code was categorized as either urban
or rural according to the Rural Urban Commuting Area Codes clas-
sifications. Association between area of primary residence and OS
was examined using Cox Proportional Hazards regression analysis
to adjust for other prognostic variables. The role of distance from
transplant center and average income were also explored. Results:
Patients coming from rural areas weremore likely to be: older, Cau-
casians, live at least 100 miles away, and have an average income
lower than $50K compared to patients coming from urban areas.
More rural patients are transplanted forMM, otherwise distribution
of diseases and disease stages were similar between the two areas.
The number of transplants performed in patients coming from rural
areas increased in the recent years. In the univariate analysis the fol-
lowing were associated with increased risk of death: patients from
rural areas, patients living more than 100 miles away, and patients
with income lower than $50K Inmultivariate analysis, among recip-
ients of autologous HSCT, patients from rural areas had an in-
creased risk of death (RR 1.18, P 5 0.016) compared to patients
from urban areas after adjusting for age, disease stage and time pe-
riod of transplant. The effect of distance and income dissipated.
Survival rates between rural and urban locations are: at 1 year
(73% vs. 78%, P 5 0.04) and at 5 years (48% vs. 54%, P 0.012).
We failed to detect a significant difference in the risk of death ac-
cording to area of residence in theHLA-identical siblingHSCT co-
hort, although this may be due to lack of statistical power.
Conclusion: The primary location of a patient’s residence may be
an independent risk factor for survival after HSCT. Specific issues
regarding the coordination of follow-up care of patients from rural
areas, as well as their health behavior and medical utilization pat-
terns post-HSCT should be studied prospectively.
